Preliminary observations on the analgesic effect of salmon calcitonin in osteolytic metastases

J. Szántó, J. Sándor

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The analgesic effect of calcitonin (MiacalcicR; Calcitonin-SandozR) was studied in 12 patients with bone metastases under double-blind conditions. 100 MRC units or placebo were injected subcutaneously daily for 28 days. The results indicated the high analgesic potency of calcitonin in advanced bone metastases. It is claimed that calcitonin may act by a mechanism different from the restoration of the altered bone stucture. Endocrinological studies are planned to elucidate the mode of action of the drug.

Original languageEnglish
Pages (from-to)266-274
Number of pages9
JournalClinical Trials Journal
Volume20
Issue number5
Publication statusPublished - 1983

Fingerprint

salmon calcitonin
Calcitonin
Analgesics
Neoplasm Metastasis
Bone and Bones
Placebos

Keywords

  • Advanced malignancy
  • analgesic effect
  • calcitonin

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Preliminary observations on the analgesic effect of salmon calcitonin in osteolytic metastases. / Szántó, J.; Sándor, J.

In: Clinical Trials Journal, Vol. 20, No. 5, 1983, p. 266-274.

Research output: Contribution to journalArticle

@article{d268c71cbb9246a0a99cc862396825e0,
title = "Preliminary observations on the analgesic effect of salmon calcitonin in osteolytic metastases",
abstract = "The analgesic effect of calcitonin (MiacalcicR; Calcitonin-SandozR) was studied in 12 patients with bone metastases under double-blind conditions. 100 MRC units or placebo were injected subcutaneously daily for 28 days. The results indicated the high analgesic potency of calcitonin in advanced bone metastases. It is claimed that calcitonin may act by a mechanism different from the restoration of the altered bone stucture. Endocrinological studies are planned to elucidate the mode of action of the drug.",
keywords = "Advanced malignancy, analgesic effect, calcitonin",
author = "J. Sz{\'a}nt{\'o} and J. S{\'a}ndor",
year = "1983",
language = "English",
volume = "20",
pages = "266--274",
journal = "Clinical Trials Journal",
issn = "0009-9325",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Preliminary observations on the analgesic effect of salmon calcitonin in osteolytic metastases

AU - Szántó, J.

AU - Sándor, J.

PY - 1983

Y1 - 1983

N2 - The analgesic effect of calcitonin (MiacalcicR; Calcitonin-SandozR) was studied in 12 patients with bone metastases under double-blind conditions. 100 MRC units or placebo were injected subcutaneously daily for 28 days. The results indicated the high analgesic potency of calcitonin in advanced bone metastases. It is claimed that calcitonin may act by a mechanism different from the restoration of the altered bone stucture. Endocrinological studies are planned to elucidate the mode of action of the drug.

AB - The analgesic effect of calcitonin (MiacalcicR; Calcitonin-SandozR) was studied in 12 patients with bone metastases under double-blind conditions. 100 MRC units or placebo were injected subcutaneously daily for 28 days. The results indicated the high analgesic potency of calcitonin in advanced bone metastases. It is claimed that calcitonin may act by a mechanism different from the restoration of the altered bone stucture. Endocrinological studies are planned to elucidate the mode of action of the drug.

KW - Advanced malignancy

KW - analgesic effect

KW - calcitonin

UR - http://www.scopus.com/inward/record.url?scp=0021042130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021042130&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0021042130

VL - 20

SP - 266

EP - 274

JO - Clinical Trials Journal

JF - Clinical Trials Journal

SN - 0009-9325

IS - 5

ER -